TipRanks
Go Ultimate55% OFF

PBE ETF Forecast & Price Targets

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

PBE Analyst Ratings

Moderate Buy
30ConsensusRatings
26Buy4Hold0Sell
Based on the Wall Street analyst consensus for 30 of PBE’s holdings.

PBE 12 Month Forecast

$125.38â–²(22.32% Upside)
Based on Wall Street analyst 12-month price targets for 30 of Invesco Dynamic Biotechnology & Genome ETF’s holdings in the last 3 months. The average price target is $125.38 with a high forecast of $160.45 and a low forecast of $86.57. The average price target represents a 22.32% change from the last price of $102.50.
Highest Price Target$160.45Average Price Target$125.38Lowest Price Target$86.57

PBE Stocks With Highest Upside Potential

PBE highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$13.43(343.19% Upside)
Strong Buy$19.25(127.27% Upside)
Strong Buy$48.71(104.68% Upside)
Moderate Buy$44.01(103.47% Upside)
Strong Buy$99.89(66.56% Upside)

PBE Stocks With Highest Downside Potential

PBE highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$127.69(-42.41% Downside)
Moderate Buy$105.86(-19.14% Downside)
Hold$57.58(-17.01% Downside)
Moderate Buy$406.71(-12.73% Downside)
Moderate Buy$889.70(-4.12% Downside)

PBE ETF FAQ

What is PBE’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 30 of PBE’s holdings, Invesco Dynamic Biotechnology & Genome ETF’s 12-month average price target is $125.38.
What is PBE’s upside potential, based on the analysts’ average price target?
PBE’s average price target of $125.38 represents a 22.32% upside from its last price of $102.50.
Is PBE a Buy, Sell or Hold?
Invesco Dynamic Biotechnology & Genome ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 30 of PBE’s holdings: 26 rated Buy, 4 rated Hold and 0 rated Sell.
What is Invesco Dynamic Biotechnology & Genome ETF’s price target?
The average price target for Invesco Dynamic Biotechnology & Genome ETF is $125.38, based on Wall Street analyst 12-month price targets for 30 of PBE’s holdings, issued in the past 3 months. The highest price target is $160.45 and the lowest is $86.57. The average price target represents a 22.32% increase from the last price of $102.50.
What is PBE’s expense ratio?
PBE’s expense ratio is 0.59%.
How many holdings does PBE have?
PBE holds 32 assets.
How can I buy shares of PBE?
You can buy shares of PBE through a brokerage account. Compare brokers on our Best Online Brokers page.